BLOG

2020 Could be a Defining Year for SQZ Biotech

If 2019 was a breakthrough year for Watertown, Mass.-based SQZ Biotech, 2020 could be a defining year as the company tests is first antigen-presenting cell asset in the clinic to treat solid tumors that are HPV positive.

Back to the Blog .st0{stroke:#000;stroke-width:3}.st0,.st1{fill:none}